Risk Factors for Preeclampsia in Clinical Practice Guidelines: Comparison With the Evidence
( BJOG. 2024;131:46–62. DOI: 10.1111/1471-0528.17320) Preeclampsia affects 2% to 4% of pregnancies globally, with a rising incidence linked to increasing maternal age and body mass. This hypertensive disorder poses significant risks to both maternal and fetal health, making it a key focus of prenatal care through blood pressure and proteinuria screening. Despite the lack of an approved treatment to modify the disease, current best practices involve identifying at-risk women, administering preventative therapy, managing hypertension, and other organ impacts if preeclampsia develops, and ultimately, timing the birth to resolve the condition.
Authors
- L.A. Magee
- H.D. Mistry
- M. Green
- Kelly Pickerill (ORCID: https://orcid.org/0000-0001-6242-857X)
- R. Townsend
- J.N. Bone
- M.L. Woo Kinshella
- Marianne Vidler (ORCID: https://orcid.org/0000-0002-7633-8812)
- Eleni Tsigas (ORCID: https://orcid.org/0000-0002-9543-202X)
- Rekha Shanmugam (ORCID: https://orcid.org/0000-0001-6390-1162)
- Helen Elwell (ORCID: https://orcid.org/0000-0002-6827-0504)
- J. Singer
- Peter von Dadelszen (ORCID: https://orcid.org/0000-0003-4136-3070)
- Véronique Filippi (ORCID: https://orcid.org/0000-0003-1331-3391)
- Terteel Elawad (ORCID: https://orcid.org/0000-0002-4432-1485)
- M.-L. Volvert
- Graham Scott
- Cristina López (ORCID: https://orcid.org/0009-0008-9608-1322)
- A. Khalil
Publication Details
- Journal
- Obstetric Anesthesia Digest
- Published
- 2024-11-19
- DOI
- https://doi.org/10.1097/01.aoa.0001080228.88108.8e
- Primary Topic
- Pregnancy and preeclampsia studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00